+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biodefense Market by Product Type (Decontamination Products, Detection Devices, Therapeutics), Pathogen Type (Bacterial Agents, Toxins, Viral Agents), Technology, Application, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Biodefense Market by Product Type (Decontamination Products, Detection Devices, Therapeutics), Pathogen Type (Bacterial Agents, Toxins, Viral Agents), Technology, Application, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Biodefense Market by Product Type (Decontamination Products, Detection Devices, Therapeutics), Pathogen Type (Bacterial Agents, Toxins, Viral Agents), Technology, Application, End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082678
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biodefense market is rapidly evolving to meet sophisticated biological threats and shifting geopolitical landscapes. Senior leaders must understand sector drivers, collaborative strategies, and essential technology investments to inform resilient defense postures and competitive decision-making.

Market Snapshot: Biodefense Market Size and Growth

The Biodefense Market grew from USD 20.33 billion in 2024 to USD 22.71 billion in 2025, with a projected CAGR of 11.35%, expected to reach USD 38.77 billion by 2030. Market expansion is underpinned by a convergence of government funding, technological advances, and cross-industry collaboration. Organizations engaged in biodefense must navigate complex supply chains, regulatory requirements, and rising threats from both natural and engineered biological agents.

Scope & Segmentation

This report delivers a structured view of the biodefense market across critical segments, applications, and regions.

  • Product Type: Decontamination products including disinfectants and personal protective equipment (PPE); detection devices such as biosensors and pathogen detection systems; therapeutics spanning antiviral therapies and monoclonal antibodies; vaccines addressing diverse threats including anthrax, botulism, and smallpox.
  • Pathogen Type: Bacterial agents, toxins, and viral agents, each requiring tailored countermeasures and detection protocols.
  • Technology: Immunoassays, mass spectrometry, next generation sequencing, and polymerase chain reaction enable rapid pathogen detection, data analysis, and targeted response.
  • Application: Detection & diagnostics, prevention, and treatment, highlighting the breadth of approaches across the biodefense continuum.
  • End User: Academic and research institutes, government and defense agencies, hospitals and clinics, and pharmaceutical and biotech companies.
  • Distribution Channel: Offline and online channels drive procurement, impact delivery timelines, and shape inventory management strategies.
  • Regions: Americas (with key US states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the UK, Germany, France, Saudi Arabia, South Africa, and others), Asia-Pacific (notably China, India, Japan, Australia, and several Southeast Asian countries).
  • Companies: Coverage includes major industry participants such as Emergent BioSolutions Inc., Siga Technologies, Xoma Corporation, Dynavax Technologies Corporation, Luminex Corporation, Bavarian Nordic A/S, Thermo Fisher Scientific, QIAGEN N.V., and more.

Key Takeaways

  • Fragmented global threats require integrated frameworks blending rapid-response, strategic policy alignment, and technology investments for effective biodefense preparedness.
  • Cross-sector alliances—spanning public, private, and academic spheres—accelerate the commercialization of next generation diagnostics, vaccines, and biosensors.
  • AI-driven analytics and scalable molecular platforms offer earlier threat detection and adaptive surveillance across a widening spectrum of pathogens.
  • Regional strategies differ: North America emphasizes domestic manufacturing, while Asia-Pacific drives R&D innovation and EMEA coordinates regulatory harmonization and joint stockpiling efforts.
  • Competitive positioning is increasingly defined by pipeline innovation, strategic collaborations, and diversification across related product lines, including PPE, antivirals, and advanced diagnostics.

Tariff Impact on Supply Chain and Resilience

  • Recent tariffs on reagents, diagnostic hardware, and protective equipment are prompting organizations to invest in local supply options and reconfigure global procurement strategies.
  • Supply chain resilience, supported by diversified sourcing and localized production, is improving quality control, inventory practices, and long-term biodefense infrastructure stability.

Methodology & Data Sources

Our analysis integrates qualitative interviews with industry experts, comprehensive literature and regulatory reviews, and primary survey responses from procurement leaders and scientific directors. This triangulated approach delivers robust, actionable market intelligence that reflects current dynamics and on-the-ground realities.

Why This Report Matters

  • Facilitates informed investment and procurement decisions by clarifying threat landscapes and competitive positioning in the biodefense market.
  • Identifies regional dynamics, technology adoption trends, and regulatory frameworks critical for successful product development and market entry.
  • Enables stakeholders to prioritize resource allocation, foster cross-sector collaboration, and anticipate disruption in both supply chain operations and biological risk management.

Conclusion

This report offers a clear, actionable overview of the biodefense market's evolving landscape. Leverage these insights to guide strategy, investment, and partnership development as the industry advances.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of AI-driven pathogen detection platforms for real-time biodefense monitoring
5.2. Surge in synthetic biology investments accelerating rapid vaccine development pipelines
5.3. Deployment of field-compatible mobile laboratories transforming on-site biodefense response readiness
5.4. Integration of genomic surveillance networks into national biodefense early warning systems
5.5. Escalating partnerships between defense agencies and biopharmaceutical firms for countermeasure R&D
5.6. Shift towards CRISPR-based diagnostic assays enabling point-of-care detection of emerging threats
5.7. Adoption of cloud-based bioinformatics platforms for global pathogen threat analysis and sharing
5.8. Government-led funding initiatives driving expansion of high-containment biodefense facilities capacity
5.9. Emergence of holistic supply chain resilience strategies to secure critical biodefense medical supplies
5.10. Regulatory harmonization efforts streamlining emergency use approval processes for novel countermeasures
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biodefense Market, by Product Type
8.1. Introduction
8.2. Decontamination Products
8.2.1. Disinfectants
8.2.2. PPE
8.3. Detection Devices
8.3.1. Biosensors
8.3.2. Pathogen Detection Systems
8.4. Therapeutics
8.4.1. Antiviral Therapies
8.4.2. Monoclonal Antibodies
8.5. Vaccines
8.5.1. Anthrax Vaccine
8.5.2. Botulism Vaccine
8.5.3. Smallpox Vaccine
9. Biodefense Market, by Pathogen Type
9.1. Introduction
9.2. Bacterial Agents
9.3. Toxins
9.4. Viral Agents
10. Biodefense Market, by Technology
10.1. Introduction
10.2. Immunoassays
10.3. Mass Spectrometry
10.4. Next Generation Sequencing
10.5. Polymerase Chain Reaction
11. Biodefense Market, by Application
11.1. Introduction
11.2. Detection & Diagnostics
11.3. Prevention
11.4. Treatment
12. Biodefense Market, by End User
12.1. Introduction
12.2. Academic & Research Institutes
12.3. Government & Defense Agencies
12.4. Hospitals & Clinics
12.5. Pharma & Biotech Companies
13. Biodefense Market, by Distribution Channel
13.1. Introduction
13.2. Offline Channels
13.3. Online Channels
14. Americas Biodefense Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Biodefense Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Biodefense Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Emergent BioSolutions Inc.
17.3.2. Siga Technologies, Inc.
17.3.3. Xoma Corporation
17.3.4. Altimmune, Inc.
17.3.5. Dynavax Technologies Corporation
17.3.6. Elusys Therapeutics, Inc.
17.3.7. Ichor Medical Systems
17.3.8. DynPort Vaccine Company LLC
17.3.9. Luminex Corporation
17.3.10. Cleveland Biolabs Inc.
17.3.11. Bavarian Nordic A/S
17.3.12. Alnylam Pharmaceuticals, Inc.
17.3.13. QIAGEN N.V.
17.3.14. Ecolab Inc.
17.3.15. Abbott Laboratories
17.3.16. Bio-Rad Laboratories
17.3.17. Nova Biomedical Corporation
17.3.18. Siemens Healthcare
17.3.19. Strados Labs
17.3.20. Thermo Fisher Scientific
17.3.21. Biofourmis Singapore Pte. Ltd.
17.3.22. SD BIOSENSOR
17.3.23. Lucentix SA
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIODEFENSE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIODEFENSE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIODEFENSE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIODEFENSE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIODEFENSE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIODEFENSE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIODEFENSE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BIODEFENSE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BIODEFENSE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BIODEFENSE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BIODEFENSE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BIODEFENSE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BIODEFENSE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. BIODEFENSE MARKET: RESEARCHAI
FIGURE 28. BIODEFENSE MARKET: RESEARCHSTATISTICS
FIGURE 29. BIODEFENSE MARKET: RESEARCHCONTACTS
FIGURE 30. BIODEFENSE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIODEFENSE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIODEFENSE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIODEFENSE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIODEFENSE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIODEFENSE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIODEFENSE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIODEFENSE MARKET SIZE, BY DISINFECTANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIODEFENSE MARKET SIZE, BY DISINFECTANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIODEFENSE MARKET SIZE, BY PPE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIODEFENSE MARKET SIZE, BY PPE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIODEFENSE MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIODEFENSE MARKET SIZE, BY BIOSENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIODEFENSE MARKET SIZE, BY PATHOGEN DETECTION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIODEFENSE MARKET SIZE, BY PATHOGEN DETECTION SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIODEFENSE MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIODEFENSE MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIODEFENSE MARKET SIZE, BY ANTIVIRAL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIODEFENSE MARKET SIZE, BY ANTIVIRAL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIODEFENSE MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIODEFENSE MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIODEFENSE MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIODEFENSE MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIODEFENSE MARKET SIZE, BY ANTHRAX VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIODEFENSE MARKET SIZE, BY ANTHRAX VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIODEFENSE MARKET SIZE, BY BOTULISM VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIODEFENSE MARKET SIZE, BY BOTULISM VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIODEFENSE MARKET SIZE, BY SMALLPOX VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIODEFENSE MARKET SIZE, BY SMALLPOX VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIODEFENSE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIODEFENSE MARKET SIZE, BY BACTERIAL AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIODEFENSE MARKET SIZE, BY BACTERIAL AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIODEFENSE MARKET SIZE, BY TOXINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIODEFENSE MARKET SIZE, BY TOXINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIODEFENSE MARKET SIZE, BY VIRAL AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIODEFENSE MARKET SIZE, BY VIRAL AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIODEFENSE MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIODEFENSE MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIODEFENSE MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIODEFENSE MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIODEFENSE MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIODEFENSE MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIODEFENSE MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIODEFENSE MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIODEFENSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIODEFENSE MARKET SIZE, BY DETECTION & DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIODEFENSE MARKET SIZE, BY DETECTION & DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIODEFENSE MARKET SIZE, BY PREVENTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIODEFENSE MARKET SIZE, BY PREVENTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIODEFENSE MARKET SIZE, BY TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIODEFENSE MARKET SIZE, BY TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIODEFENSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIODEFENSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIODEFENSE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIODEFENSE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIODEFENSE MARKET SIZE, BY GOVERNMENT & DEFENSE AGENCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIODEFENSE MARKET SIZE, BY GOVERNMENT & DEFENSE AGENCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIODEFENSE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIODEFENSE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIODEFENSE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIODEFENSE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BIODEFENSE MARKET SIZE, BY OFFLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BIODEFENSE MARKET SIZE, BY OFFLINE CHANNELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BIODEFENSE MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BIODEFENSE MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS BIODEFENSE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS BIODEFENSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS BIODEFENSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS BIODEFENSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS BIODEFENSE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES BIODEFENSE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES BIODEFENSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES BIODEFENSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES BIODEFENSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES BIODEFENSE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES BIODEFENSE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 131. CANADA BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. CANADA BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2024 (USD MILLION)
TABLE 134. CANADA BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2025-2030 (USD MILLION)
TABLE 135. CANADA BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 136. CANADA BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 137. CANADA BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 138. CANADA BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 139. CANADA BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 140. CANADA BIODEFENSE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 141. CANADA BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 142. CANADA BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 143. CANADA BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 144. CANADA BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 145. CANADA BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. CANADA BIODEFENSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. CANADA BIODEFENSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. CANADA BIODEFENSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. CANADA BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. CANADA BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. MEXICO BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. MEXICO BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. MEXICO BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2024 (USD MILLION)
TABLE 154. MEXICO BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2025-2030 (USD MILLION)
TABLE 155. MEXICO BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 156. MEXICO BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 157. MEXICO BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 158. MEXICO BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 160. MEXICO BIODEFENSE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 161. MEXICO BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 164. MEXICO BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 165. MEXICO BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. MEXICO BIODEFENSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. MEXICO BIODEFENSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. MEXICO BIODEFENSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. MEXICO BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. MEXICO BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL BIODEFENSE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL BIODEFENSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL BIODEFENSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL BIODEFENSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA BIODEFENSE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA BIODEFENSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA BIODEFENSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA BIODEFENSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. GERMANY BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 254. GERMANY BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 255. GERMANY BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2024 (USD MILLION)
TABLE 256. GERMANY BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2025-2030 (USD MILLION)
TABLE 257. GERMANY BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 258. GERMANY BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 259. GERMANY BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 260. GERMANY BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 261. GERMANY BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 262. GERMANY BIODEFENSE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 263. GERMANY BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 264. GERMANY BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 265. GERMANY BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 266. GERMANY BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 267. GERMANY BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. GERMANY BIODEFENSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. GERMANY BIODEFENSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. GERMANY BIODEFENSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. GERMANY BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. GERMANY BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. FRANCE BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. FRANCE BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. FRANCE BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2024 (USD MILLION)
TABLE 276. FRANCE BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2025-2030 (USD MILLION)
TABLE 277. FRANCE BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 278. FRANCE BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 279. FRANCE BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 280. FRANCE BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 281. FRANCE BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 282. FRANCE BIODEFENSE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 283. FRANCE BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 284. FRANCE BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 285. FRANCE BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 286. FRANCE BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 287. FRANCE BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. FRANCE BIODEFENSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. FRANCE BIODEFENSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. FRANCE BIODEFENSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. FRANCE BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. FRANCE BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA BIODEFENSE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA BIODEFENSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA BIODEFENSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA BIODEFENSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. ITALY BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 314. ITALY BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 315. ITALY BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2024 (USD MILLION)
TABLE 316. ITALY BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2025-2030 (USD MILLION)
TABLE 317. ITALY BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 318. ITALY BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 319. ITALY BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 320. ITALY BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 321. ITALY BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 322. ITALY BIODEFENSE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 323. ITALY BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 324. ITALY BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 325. ITALY BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 326. ITALY BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 327. ITALY BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 328. ITALY BIODEFENSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 329. ITALY BIODEFENSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. ITALY BIODEFENSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. ITALY BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. ITALY BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 333. SPAIN BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 334. SPAIN BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 335. SPAIN BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2024 (USD MILLION)
TABLE 336. SPAIN BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2025-2030 (USD MILLION)
TABLE 337. SPAIN BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 338. SPAIN BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 339. SPAIN BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 340. SPAIN BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 341. SPAIN BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 342. SPAIN BIODEFENSE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 343. SPAIN BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 344. SPAIN BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 345. SPAIN BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 346. SPAIN BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 347. SPAIN BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 348. SPAIN BIODEFENSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 349. SPAIN BIODEFENSE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 350. SPAIN BIODEFENSE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 351. SPAIN BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 352. SPAIN BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 353. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 354. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 355. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2024 (USD MILLION)
TABLE 356. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2025-2030 (USD MILLION)
TABLE 357. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 359. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 360. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 361. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 362. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 363. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2024 (USD MILLION)
TABLE 364. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2025-2030 (USD MILLION)
TABLE 365. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 366. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 367. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 368. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TAB

Samples

Loading
LOADING...

Companies Mentioned

  • Emergent BioSolutions Inc.
  • Siga Technologies, Inc.
  • Xoma Corporation
  • Altimmune, Inc.
  • Dynavax Technologies Corporation
  • Elusys Therapeutics, Inc.
  • Ichor Medical Systems
  • DynPort Vaccine Company LLC
  • Luminex Corporation
  • Cleveland Biolabs Inc.
  • Bavarian Nordic A/S
  • Alnylam Pharmaceuticals, Inc.
  • QIAGEN N.V.
  • Ecolab Inc.
  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Nova Biomedical Corporation
  • Siemens Healthcare
  • Strados Labs
  • Thermo Fisher Scientific
  • Biofourmis Singapore Pte. Ltd.
  • SD BIOSENSOR
  • Lucentix SA

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 22.71 Billion
Forecasted Market Value ( USD ) by 2030 $ 38.77 Billion
Compound Annual Growth Rate11.3%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Biodefense - Global Strategic Business Report - Product Image

Biodefense - Global Strategic Business Report

  • Report
  • 363 Pages
  • Global
From
Biodefense Market by Technology, Product, Application, and Region - Global Forecast to 2030 - Product Image

Biodefense Market by Technology, Product, Application, and Region - Global Forecast to 2030

  • Report
  • 218 Pages
  • Global
From
Biodefense Market Report 2025 - Product Image

Biodefense Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Biodefense - A Global Market Overview - Product Image

Biodefense - A Global Market Overview

  • Report
  • 255 Pages
  • Global
From
Bio-Detection - Global Strategic Business Report - Product Image

Bio-Detection - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From

About the Biodefense Market

The Biodefense market is a sector of the biotechnology industry that focuses on the development of products and services to protect against biological threats. This includes the development of vaccines, diagnostics, and treatments for infectious diseases, as well as the development of countermeasures to protect against bioterrorism. Biodefense products are designed to protect against a wide range of biological agents, including bacteria, viruses, and toxins. The Biodefense market is driven by the need to protect against the increasing threat of biological agents, as well as the need to develop treatments for existing and emerging infectious diseases. Governments, healthcare organizations, and private companies are investing in the development of biodefense products and services. Some of the major companies in the Biodefense market include Emergent BioSolutions, GlaxoSmithKline, Johnson & Johnson, Merck, Novavax, Pfizer, and Sanofi. These companies are developing a range of products and services to protect against biological threats, including vaccines, diagnostics, and treatments. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.